Polycystic ovary syndrome is the most prevalent endocrine-metabolic pathology in pre-menopausal women. Its etiopathogenesis is complex, multifactorial and heterogeneous, including the interaction of genetic, epigenetic and environmental factors. Androgenic excess constitutes the disease's main physiopathological mechanism and results in reproductive, metabolic and cosmetic alterations which negatively impact these patients' quality of life. The criteria established in the Rotterdam consensus and their correct application form the necessary basis for this syndrome's proper diagnosis. In the absence of an aetiological treatment, the aim is to improve the clinical signs and symptoms derived from hyperandrogenism, ovarian dysfunction and existing metabolic complications, and, therefore, they must be chronic and individualised.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.medcli.2018.11.019 | DOI Listing |
Syst Biol Reprod Med
December 2025
Department of Molecular Endocrinology, ICMR- National Institute for Research in Reproductive and Child Health, Parel, Mumbai, India.
Polycystic ovary syndrome (PCOS) is a complex polygenic endocrinopathy affecting 5-20% of reproductive-age women. Familial studies, candidate gene studies, and GWAS have identified multiple PCOS-associated genetic loci. This study aims to identify the functional variants associated with PCOS.
View Article and Find Full Text PDFFront Med (Lausanne)
February 2025
The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Introduction: The current study demonstrated that oxidative stress (OS) is closely related to the pathogenesis of polycystic ovary syndrome (PCOS). However, there are numerous factors that lead to OS, therefore, identifying the key genes associated with PCOS that contribute to OS is crucial for elucidating the pathogenesis of PCOS and selecting appropriate treatment strategies.
Methods: Four datasets (GSE95728, GSE106724, GSE138572, and GSE145296) were downloaded from the gene expression omnibus (GEO) database.
J Ovarian Res
March 2025
Department of Obstetrics, The Affiliated Hospital of Qingdao University, 59 Haier Road, Qingdao, 266000, China.
Purpose: Polycystic ovary syndrome (PCOS) is currently recognized as a condition that affects several systems in the body, including the reproductive, endocrine, and cardiovascular systems. Prevalent among teenagers and women of reproductive age. Prior research has demonstrated an elevation of miR-34a-5p within the follicular fluid (FF) of women of PCOS.
View Article and Find Full Text PDFSci Rep
March 2025
Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Polycystic ovary syndrome (PCOS) is the most common cause of infertility in reproductive-age women, and its etiology and exact treatment are not yet established. Adropin is a unique hepatokine involved in maintaining energy homeostasis, and its level has been reported to decline in serum and follicular fluid of PCOS women. Thus, present study was designed to investigate the effect of adropin on hormonal and reproductive abnormalities in PCOS mice.
View Article and Find Full Text PDFJBRA Assist Reprod
March 2025
Department of Pharmaceutical Chemistry, Vivekanand Education Society's College of Pharmacy Affiliated to University of Mumbai, Chembur, Mumbai-400074, India.
Objective: With one in ten women globally suffering from it, polycystic ovarian syndrome (PCOS) has recently emerged as one of the most common endocrine multifactorial illnesses. Each patient may not experience all the potential symptoms of PCOS, which include insulin resistance, hirsutism, acanthosis nigricans, hyperandrogenism, weight gain, etc.
Methods: Although symptomatic treatments like ovarian drilling procedures or cosmetic lotions to alleviate hirsutism do not address the underlying cause, there is still no comprehensive treatment for PCOS.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!